Erasca, Inc. License Agreements
4 Contracts & Agreements
- Amended and Restated License Agreement, dated November 23, 2020, by and among the Registrants wholly-owned subsidiaries, ASN Product Development, Inc. and Asana BioSciences, LLC (Filed With SEC on June 25, 2021)
- Exclusive License Agreement, dated March 12, 2020, by and between Katmai Pharmaceuticals, Inc. and the Registrant (Filed With SEC on June 25, 2021)
- License Agreement, dated February 18, 2020, by and between NiKang Therapeutics, Inc. and the Registrant (Filed With SEC on June 25, 2021)
- Exclusive License Agreement, dated December 21, 2018, by and between The Regents of the University of California and the Registrant, as amended (Filed With SEC on June 25, 2021)